Revenue
No reported data
Faeth Therapeutics, Inc. (FTH)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Operating expenses | $22.3M | $32.6M | $37.1M | $50.2M | $37.5M | $19.5M |
| Operating income | −$22.3M | −$32.6M | −$37.1M | −$50.2M | −$37.5M | −$19.5M |
| EBITDAderived | −$22.2M | −$32.1M | −$36.5M | −$49.6M | −$36.8M | −$19.2M |
| Net income | −$21.1M | −$30.2M | −$34.1M | −$48.6M | −$36.8M | −$20.1M |
| Basic EPSper diluted share | -$16.72 | -$24.01 | -$1.22 | -$1.58 | -$1.33 | -$12.53 |
| Diluted EPSper diluted share | -$16.72 | -$24.01 | -$1.22 | -$1.58 | -$1.33 | -$12.53 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 26, 2026Form 4 | STEPHENSON BRIAN CChief Financial Officer | BuyCommon Stock · indirect | 100 | $26.39 | $2.6K | 33.1K |
| Jun 26, 2026Form 4 | STEPHENSON BRIAN CChief Financial Officer | BuyCommon Stock · indirect | 1.4K | $25.55 | $34.7K | 33.0K |
| Jun 26, 2026Form 4 | STEPHENSON BRIAN CChief Financial Officer | BuyCommon Stock · indirect | 4.2K | $24.90 | $104.9K | 31.6K |
| Jun 26, 2026Form 4 | STEPHENSON BRIAN CChief Financial Officer | BuyCommon Stock · indirect | 580 | $23.61 | $13.7K | 27.4K |
| Jun 24, 2026Form 4 | STEPHENSON BRIAN CChief Financial Officer | BuyCommon Stock · indirect | 100 | $27.77 | $2.8K | 26.8K |